Michel C, al Khayat R, Viron B, Siohan P, Mignon F
Service de néphrologie et A.U.R.A., Hôpital Tenon, Paris.
Nephrologie. 1995;16(1):55-69.
There have been improvements in the technique of peritoneal dialysis (PD) over the last ten years. However, peritoneal infections remain the major complication associated with this treatment, and the risk of infection cannot be accurately predicted. Nevertheless, it is widely accepted that simple connections should be replaced by improved systems of connection, and that patient training is important. Peritoneal infection should be suspected when the dialysate is turbid, whether or not associated with peritoneal irritation. None of the various techniques used for the culture of dialysates has been shown to be either more sensitive or more specific than any of the others. Thus, collaboration between the physicians supervising the dialysis and microbiologists is necessary to choose the culture techniques best adapted. The sensitivity should be at least 85 to 90%. If the sensitivity is lower, the techniques used should be reconsidered. There have been several hundred publications assessing treatments of peritoneal infections associated with PD. However, no particular antibiotic treatment has been demonstrated to be systematically superior. The use of associated antibiotics seems to be preferable initially, until the causative agent has been identified. For example, vancomycin with a third generation cephalosporin seems to be the association of choice, because of its efficacy, tolerance and ease of use. The optimal duration of treatment has not been established by randomised study, but 10 days is commonly used for Gram-positive infections, and longer for Gram-negative. Whatever the treatment used, the success rate should be at least 80 to 90%. Randomised trials with sufficiently large numbers of patients are required to determine the indications and delay before withdrawal of the DP catheter in cases of peritonitis which do not respond to antibiotics.
在过去十年中,腹膜透析(PD)技术已有改进。然而,腹膜感染仍然是与这种治疗相关的主要并发症,且感染风险无法准确预测。尽管如此,人们普遍认为应将简单连接方式替换为改进的连接系统,并且患者培训很重要。当透析液浑浊时,无论是否伴有腹膜刺激,都应怀疑有腹膜感染。用于透析液培养的各种技术中,没有一种被证明比其他技术更敏感或更具特异性。因此,负责透析的医生与微生物学家之间的合作对于选择最适用的培养技术是必要的。敏感性应至少为85%至90%。如果敏感性较低,则应重新考虑所使用的技术。已有数百篇关于评估与PD相关的腹膜感染治疗的出版物。然而,没有哪种特定的抗生素治疗被证明在各方面都更具优势。在确定病原体之前,最初使用联合抗生素似乎更可取。例如,万古霉素与第三代头孢菌素联合似乎是首选组合,因其疗效、耐受性和易用性。治疗的最佳持续时间尚未通过随机研究确定,但革兰氏阳性感染通常使用10天,革兰氏阴性感染则使用更长时间。无论采用何种治疗方法,成功率应至少为80%至90%。需要进行有足够多患者的随机试验,以确定在腹膜炎对抗生素无反应的情况下拔除腹膜透析导管的指征和时机。